ahlam1399
08-19-2016, 06:28 PM
BRIEF-Portola Pharmaceuticals an**unces IndexXa review update
* Portola pharmaceuticals an**unces validation of marketingauthorization application (maa) by European Medicines Agency(ema) for indexxa (andexanet alfa), a factor xa inhibitorantidotehttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=BjgGkoimp8A:4-y8NK_XrCQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BjgGkoimp8A:4-y8NK_XrCQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=BjgGkoimp8A:4-y8NK_XrCQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BjgGkoimp8A:4-y8NK_XrCQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=BjgGkoimp8A:4-y8NK_XrCQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/BjgGkoimp8A
* Portola pharmaceuticals an**unces validation of marketingauthorization application (maa) by European Medicines Agency(ema) for indexxa (andexanet alfa), a factor xa inhibitorantidotehttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=BjgGkoimp8A:4-y8NK_XrCQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BjgGkoimp8A:4-y8NK_XrCQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=BjgGkoimp8A:4-y8NK_XrCQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=BjgGkoimp8A:4-y8NK_XrCQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=BjgGkoimp8A:4-y8NK_XrCQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/BjgGkoimp8A